Cargando…
Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort
BACKGROUND: 27-hydroxycholesterol (HC) and 25-HC were identified as endogenous selective estrogen receptor modulators (SERMs) and estrogen receptor (ER) modulators, respectively. They are hypothesized to play a role in multiple physiologic processes and pathologies, including breast cancer developme...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403581/ https://www.ncbi.nlm.nih.gov/pubmed/37355720 http://dx.doi.org/10.1038/s41416-023-02315-w |
_version_ | 1785085100405293056 |
---|---|
author | Decker, Nina Sophia Johnson, Theron Behrens, Sabine Obi, Nadia Kaaks, Rudolf Chang-Claude, Jenny Fortner, Renée Turzanski |
author_facet | Decker, Nina Sophia Johnson, Theron Behrens, Sabine Obi, Nadia Kaaks, Rudolf Chang-Claude, Jenny Fortner, Renée Turzanski |
author_sort | Decker, Nina Sophia |
collection | PubMed |
description | BACKGROUND: 27-hydroxycholesterol (HC) and 25-HC were identified as endogenous selective estrogen receptor modulators (SERMs) and estrogen receptor (ER) modulators, respectively. They are hypothesized to play a role in multiple physiologic processes and pathologies, including breast cancer development and progression. METHODS: We evaluated circulating 27-HC and 25-HC, and outcomes following a breast cancer diagnosis in 2282 women from the MARIE study over median follow-up of 11.6 years. 27-HC and 25-HC were quantified by liquid chromatography–mass spectrometry. We calculated hazard ratios (HR) and 95% confidence intervals [CI] using multivariable Cox Proportional Hazards regression. RESULTS: We observed no associations between 27-HC and breast cancer prognosis overall. Associations between 27-HC and survival differed by circulating estradiol concentrations and endocrine therapy, but not by hormone receptor status. Among women with estradiol levels below the median (0.08 nM), 27-HC was associated with higher risk of all-cause mortality (HR(log2) = 1.80 [1.20–2.71]) and breast cancer-specific mortality (HR(log2) = 1.95 [1.14-3.31]). No associations were observed in women with estradiol levels above the median. Higher 25-HC levels were associated with lower risk of recurrence (HR(log2) = 0.87 [0.77-0.98]). CONCLUSION: Associations between 27-HC and breast cancer prognosis varied by circulating estradiol levels and endocrine therapy. Less consistent results were observed for 25-HC. |
format | Online Article Text |
id | pubmed-10403581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-104035812023-08-06 Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort Decker, Nina Sophia Johnson, Theron Behrens, Sabine Obi, Nadia Kaaks, Rudolf Chang-Claude, Jenny Fortner, Renée Turzanski Br J Cancer Article BACKGROUND: 27-hydroxycholesterol (HC) and 25-HC were identified as endogenous selective estrogen receptor modulators (SERMs) and estrogen receptor (ER) modulators, respectively. They are hypothesized to play a role in multiple physiologic processes and pathologies, including breast cancer development and progression. METHODS: We evaluated circulating 27-HC and 25-HC, and outcomes following a breast cancer diagnosis in 2282 women from the MARIE study over median follow-up of 11.6 years. 27-HC and 25-HC were quantified by liquid chromatography–mass spectrometry. We calculated hazard ratios (HR) and 95% confidence intervals [CI] using multivariable Cox Proportional Hazards regression. RESULTS: We observed no associations between 27-HC and breast cancer prognosis overall. Associations between 27-HC and survival differed by circulating estradiol concentrations and endocrine therapy, but not by hormone receptor status. Among women with estradiol levels below the median (0.08 nM), 27-HC was associated with higher risk of all-cause mortality (HR(log2) = 1.80 [1.20–2.71]) and breast cancer-specific mortality (HR(log2) = 1.95 [1.14-3.31]). No associations were observed in women with estradiol levels above the median. Higher 25-HC levels were associated with lower risk of recurrence (HR(log2) = 0.87 [0.77-0.98]). CONCLUSION: Associations between 27-HC and breast cancer prognosis varied by circulating estradiol levels and endocrine therapy. Less consistent results were observed for 25-HC. Nature Publishing Group UK 2023-06-24 2023-08-24 /pmc/articles/PMC10403581/ /pubmed/37355720 http://dx.doi.org/10.1038/s41416-023-02315-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Decker, Nina Sophia Johnson, Theron Behrens, Sabine Obi, Nadia Kaaks, Rudolf Chang-Claude, Jenny Fortner, Renée Turzanski Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort |
title | Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort |
title_full | Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort |
title_fullStr | Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort |
title_full_unstemmed | Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort |
title_short | Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort |
title_sort | endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: results from the marie patient cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403581/ https://www.ncbi.nlm.nih.gov/pubmed/37355720 http://dx.doi.org/10.1038/s41416-023-02315-w |
work_keys_str_mv | AT deckerninasophia endogenousestrogenreceptormodulatingoxysterolsandbreastcancerprognosisresultsfromthemariepatientcohort AT johnsontheron endogenousestrogenreceptormodulatingoxysterolsandbreastcancerprognosisresultsfromthemariepatientcohort AT behrenssabine endogenousestrogenreceptormodulatingoxysterolsandbreastcancerprognosisresultsfromthemariepatientcohort AT obinadia endogenousestrogenreceptormodulatingoxysterolsandbreastcancerprognosisresultsfromthemariepatientcohort AT kaaksrudolf endogenousestrogenreceptormodulatingoxysterolsandbreastcancerprognosisresultsfromthemariepatientcohort AT changclaudejenny endogenousestrogenreceptormodulatingoxysterolsandbreastcancerprognosisresultsfromthemariepatientcohort AT fortnerreneeturzanski endogenousestrogenreceptormodulatingoxysterolsandbreastcancerprognosisresultsfromthemariepatientcohort |